Clinical Trial: Assessment of Interactions Between Methamphetamine and Aripiprazole - 1
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Assessment of Interactions Between IV Methamphetamine and Aripiprazole
Brief Summary: The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.
Detailed Summary: This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripiprazole.
Sponsor: National Institute on Drug Abuse (NIDA)
Current Primary Outcome:
- Adverse effect measures
- pharmacokinetic assessment
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: National Institute on Drug Abuse (NIDA)
Dates:
Date Received: August 5, 2004
Date Started: June 2004
Date Completion: March 2005
Last Updated: January 10, 2017
Last Verified: July 2005
